Investigating the anticancer potential and apoptotic signaling of nanocapsule-loaded pyrogallol in ovarian cancer cells (A2780)

[Display omitted] Nanoencapsulation technology enables the efficient delivery of natural bioactive compounds, enhancing stability and controlled release to improve bioavailability and therapeutic efficacy. Pyrogallol, a natural polyphenolic compound, has shown promising anticancer activities against...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Results in Chemistry 2024-10, Vol.11, p.101772, Article 101772
Hauptverfasser: Ghasemi, Elham, Bamoharram, Fatemeh F., Karimi, Ehsan, Meghdadi, Pegah
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] Nanoencapsulation technology enables the efficient delivery of natural bioactive compounds, enhancing stability and controlled release to improve bioavailability and therapeutic efficacy. Pyrogallol, a natural polyphenolic compound, has shown promising anticancer activities against various cancer cell lines. The purpose of this study was to synthesize and characterize nanocapsule-encapsulated pyrogallol (Na-Pyr) and investigate its anticancer potential, apoptotic signaling, and anti-metastatic properties. The process involved synthesizing the nanocapsules using the sol–gel method and evaluating their physical and chemical properties using various techniques. The MTT assay was used to test Na-Pyr’s cytotoxicity against various cancer cell lines, including ovarian cancer (A2780), human colorectal adenocarcinoma (HT-29), and pancreatic cancer (ASPC-1), with Huvec serving as the normal cell line. DAPI staining, real-time PCR, and flow cytometry were performed to examine apoptosis induction and cell cycle arrest. The results obtained from dynamic light scattering (DLS) manifested that Na-Pyr had a size of 176.4 ± 7.26 nm, an average zeta potential of about 42.1 ± 2.01 mV, and a polydispersity (PDI) index of 0.174 ± 0.02. Electron microscopy images exhibited a smooth surface and spherical shape, indicating material compatibility. Na-Pyr exhibited higher anticancer potential against ovarian cancer cells than HT-29 and ASPC-1 cancer cell lines with an IC50 value of 23.5 ± 0.95 μg/mL. Na-Pyr significantly modulates the Bax/Bcl2 ratio and activates the MMP9 pathway-mediated apoptosis. Flow cytometry analysis supported these findings, revealing increased percentages of necrotic, early apoptotic, and late apoptotic populations upon exposure to Na-Pyr. In conclusion, the study highlights the promising anticancer potential of Na-Pyr and its potential as an effective treatment strategy.
ISSN:2211-7156
2211-7156
DOI:10.1016/j.rechem.2024.101772